4.7 Meeting Abstract

Frequency of PD-L1 positivity and microsatellite instability (MSI) in the DANTE trial: Perioperative atezolizumab with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma. A randomized, open-label phase IIb trial of the German gastric group at the AIO and SAKK

Journal

ANNALS OF ONCOLOGY
Volume 32, Issue -, Pages S1069-S1070

Publisher

ELSEVIER
DOI: 10.1016/j.annonc.2021.08.1539

Keywords

-

Categories

Funding

  1. F. Hoffmann-La Roche Ltd.

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available